ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RNXT vs BOLD // 10Y YIELD & FRED MACRO BETA

RenovoRx Inc. (NASDAQ) VS. Boundless Bio Inc. (NASDAQ) • 15-METRIC TALLY: RNXT 2 — BOLD 1
■ METRIC PARITY
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RNXT VS. BOLD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RNXT BOLD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 70.90% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -16.32% — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 180.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.40 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 3/9 +1.00 RNXT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.0 43.9 -0.90 BOLD /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $56.9M $56.4M $477.4K RNXT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RNXT REV BOLD REV RNXT GROSS % BOLD GROSS % RNXT FCF BOLD FCF
FY 2025 $1.1M $177.9M 70.9% — -$11.0M -$47.2M
FY 2024 $43.0K $205.1M 98.0% — -$9.1M -$63.4M
FY 2023 $31.9M $153.4M — — -$10.3M -$46.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RNXT // BETA —
BOLD // BETA —